photo walkheader_zpsd5bunpmi.png

Category Archives: Medical Research

2016 ASCO Practice Guidelines for Advanced Pancreatic Cancer

2016 ASCO PRACTICE GUIDELINES FOR ADVANCED ADENOCARCINOMA OF THE PANCREAS Davendra P.S. Sohal, Pamela B. Mangu, Alok A. Khorana, Manish A. Shah, Philip A. Philip, Eileen M. O’Reilly, Hope E. Uronis, Ramesh K. Ramanathan, Christopher H. Crane, Anitra Engebretson, Joseph T. Ruggiero, Mehmet S. Copur, Michelle Lau, Susan Urba and Daniel Laheru   Abstract Purpose: […]

MRI Screening Protocol for Pancreatic Cancer as Surveillance for High Risk Family Members

About 10% of those diagnosed with pancreatic cancer (ductal adenocarcinoma of the pancreas) are found to have a reasonably strong pancreatic cancer family history or that of another genetic complex or syndrome which tends to include pancreatic cancer. Consequently, many family members often ask us or their medical teams what their risks are, and what […]

“Modified” FOLFIRINOX Regimen Approved by FDA for 2nd Line Treatment of Pancreatic Cancer

On the 22nd of October, 2015, the U.S. Food and Drug Administration approved a new combination therapy that includes the drug Onivyde for patients with metastatic pancreatic cancer (ductal adenocarcinoma of the pancreas) who had earlier been treated until progression of disease while on gemcitabine or a gemcitabine-based regimen. Onivyde is liposomal irinotecan, a topoisomerase I […]

Page 6 of 25« First...45678...20...Last »
Facebook
Facebook